Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico

To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bispho...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Korean Association of Oral and Maxillofacial Surgeons 2016, 42(6), , pp.365-369
Main Authors: Cuevas-González, María Verónica, Díaz-Aguirre, Celia Minerva, Echevarría-Y-Pérez, Enrique, Cuevas-González, Juan Carlos
Format: Article
Language:English
Subjects:
Original
치의학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3
cites cdi_FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3
container_end_page 369
container_issue 6
container_start_page 365
container_title Journal of the Korean Association of Oral and Maxillofacial Surgeons
container_volume 42
creator Cuevas-González, María Verónica
Díaz-Aguirre, Celia Minerva
Echevarría-Y-Pérez, Enrique
Cuevas-González, Juan Carlos
description To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bisphosphonates; an intraoral examination was performed by 2 standardized examiners. The prevalence of bisphosphonate-related necrosis in 75 patients was 2.6%; the most common malignancy was breast cancer (84.0%), followed by prostate cancer (16.0%). Exostosis was present in 9.3% of patients and the mean Decayed, Missing, Filled Teeth index was 4.64; 44.0% of the study group had a Community Periodontal Index value between 2 and 2.9 (mean, 0.60). A detailed intraoral assessment must be performed before initiating treatment with bisphosphonates to identify risk factors for osteonecrosis.
doi_str_mv 10.5125/jkaoms.2016.42.6.365
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_1293027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1855790122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3</originalsourceid><addsrcrecordid>eNpVUdtuEzEQXSEQrUL_ACE_wkMW27u2sy9IVQVtpaIiVJ6tWXu2cbKxg-208B98MN4kVMWSNaOZM2cup6reMloLxsXH1RrCJtWcMlm3vJZ1I8WL6pTzpp2LrqEvj74Sgp5UZymtaHmSq0bx19UJX1DRdFSdVn--RXyAEb1BEgYSUsbg0cSQXJoCeYlkBY8EvCUhwkjMEiKYjNGl7MweE7wJY7h3hmwhO_Q5kRwRMlry6PKS9C5tl2H6vgQTgbynvUSPE-NVSblcnEL1FX85E95UrwYYE54d7az68eXz3cXV_Ob28vri_GZuyhp53lkmJe0FqNYgDFQNQillQdkFG5QUTHIKXJiu69VgpbBgTcFLKmzPGw7NrPpw4PVx0GvjdAC3t_dBr6M-_353rRkv5yx3m1WfDtjtrt-gNWXNMrzeRreB-Htf-X_Gu2XhedCCl7u3vBC8PxLE8HOHKeuNSwbHETyGXdJsIYTqKOMTtD1AJx1SxOGpDaN60l8f9NeT_rrlWuqifyl793zEp6J_ajd_ATZLsY8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1855790122</pqid></control><display><type>article</type><title>Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico</title><source>PubMed Central</source><creator>Cuevas-González, María Verónica ; Díaz-Aguirre, Celia Minerva ; Echevarría-Y-Pérez, Enrique ; Cuevas-González, Juan Carlos</creator><creatorcontrib>Cuevas-González, María Verónica ; Díaz-Aguirre, Celia Minerva ; Echevarría-Y-Pérez, Enrique ; Cuevas-González, Juan Carlos</creatorcontrib><description>To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bisphosphonates; an intraoral examination was performed by 2 standardized examiners. The prevalence of bisphosphonate-related necrosis in 75 patients was 2.6%; the most common malignancy was breast cancer (84.0%), followed by prostate cancer (16.0%). Exostosis was present in 9.3% of patients and the mean Decayed, Missing, Filled Teeth index was 4.64; 44.0% of the study group had a Community Periodontal Index value between 2 and 2.9 (mean, 0.60). A detailed intraoral assessment must be performed before initiating treatment with bisphosphonates to identify risk factors for osteonecrosis.</description><identifier>ISSN: 2234-7550</identifier><identifier>EISSN: 2234-5930</identifier><identifier>DOI: 10.5125/jkaoms.2016.42.6.365</identifier><identifier>PMID: 28053907</identifier><language>eng</language><publisher>Korea (South): The Korean Association of Oral and Maxillofacial Surgeons</publisher><subject>Original ; 치의학</subject><ispartof>대한구강악안면외과학회지, 2016, 42(6), , pp.365-369</ispartof><rights>Copyright © 2016 The Korean Association of Oral and Maxillofacial Surgeons. All rights reserved. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3</citedby><cites>FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3</cites><orcidid>0000-0003-3112-4893 ; 0000-0002-1250-2564 ; 0000-0002-5147-9133 ; 0000-0002-6981-8025</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206242/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206242/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28053907$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002175098$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Cuevas-González, María Verónica</creatorcontrib><creatorcontrib>Díaz-Aguirre, Celia Minerva</creatorcontrib><creatorcontrib>Echevarría-Y-Pérez, Enrique</creatorcontrib><creatorcontrib>Cuevas-González, Juan Carlos</creatorcontrib><title>Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico</title><title>Journal of the Korean Association of Oral and Maxillofacial Surgeons</title><addtitle>J Korean Assoc Oral Maxillofac Surg</addtitle><description>To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bisphosphonates; an intraoral examination was performed by 2 standardized examiners. The prevalence of bisphosphonate-related necrosis in 75 patients was 2.6%; the most common malignancy was breast cancer (84.0%), followed by prostate cancer (16.0%). Exostosis was present in 9.3% of patients and the mean Decayed, Missing, Filled Teeth index was 4.64; 44.0% of the study group had a Community Periodontal Index value between 2 and 2.9 (mean, 0.60). A detailed intraoral assessment must be performed before initiating treatment with bisphosphonates to identify risk factors for osteonecrosis.</description><subject>Original</subject><subject>치의학</subject><issn>2234-7550</issn><issn>2234-5930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVUdtuEzEQXSEQrUL_ACE_wkMW27u2sy9IVQVtpaIiVJ6tWXu2cbKxg-208B98MN4kVMWSNaOZM2cup6reMloLxsXH1RrCJtWcMlm3vJZ1I8WL6pTzpp2LrqEvj74Sgp5UZymtaHmSq0bx19UJX1DRdFSdVn--RXyAEb1BEgYSUsbg0cSQXJoCeYlkBY8EvCUhwkjMEiKYjNGl7MweE7wJY7h3hmwhO_Q5kRwRMlry6PKS9C5tl2H6vgQTgbynvUSPE-NVSblcnEL1FX85E95UrwYYE54d7az68eXz3cXV_Ob28vri_GZuyhp53lkmJe0FqNYgDFQNQillQdkFG5QUTHIKXJiu69VgpbBgTcFLKmzPGw7NrPpw4PVx0GvjdAC3t_dBr6M-_353rRkv5yx3m1WfDtjtrt-gNWXNMrzeRreB-Htf-X_Gu2XhedCCl7u3vBC8PxLE8HOHKeuNSwbHETyGXdJsIYTqKOMTtD1AJx1SxOGpDaN60l8f9NeT_rrlWuqifyl793zEp6J_ajd_ATZLsY8</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Cuevas-González, María Verónica</creator><creator>Díaz-Aguirre, Celia Minerva</creator><creator>Echevarría-Y-Pérez, Enrique</creator><creator>Cuevas-González, Juan Carlos</creator><general>The Korean Association of Oral and Maxillofacial Surgeons</general><general>대한구강악안면외과학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0003-3112-4893</orcidid><orcidid>https://orcid.org/0000-0002-1250-2564</orcidid><orcidid>https://orcid.org/0000-0002-5147-9133</orcidid><orcidid>https://orcid.org/0000-0002-6981-8025</orcidid></search><sort><creationdate>20161201</creationdate><title>Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico</title><author>Cuevas-González, María Verónica ; Díaz-Aguirre, Celia Minerva ; Echevarría-Y-Pérez, Enrique ; Cuevas-González, Juan Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Original</topic><topic>치의학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cuevas-González, María Verónica</creatorcontrib><creatorcontrib>Díaz-Aguirre, Celia Minerva</creatorcontrib><creatorcontrib>Echevarría-Y-Pérez, Enrique</creatorcontrib><creatorcontrib>Cuevas-González, Juan Carlos</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Journal of the Korean Association of Oral and Maxillofacial Surgeons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cuevas-González, María Verónica</au><au>Díaz-Aguirre, Celia Minerva</au><au>Echevarría-Y-Pérez, Enrique</au><au>Cuevas-González, Juan Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico</atitle><jtitle>Journal of the Korean Association of Oral and Maxillofacial Surgeons</jtitle><addtitle>J Korean Assoc Oral Maxillofac Surg</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>42</volume><issue>6</issue><spage>365</spage><epage>369</epage><pages>365-369</pages><issn>2234-7550</issn><eissn>2234-5930</eissn><abstract>To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bisphosphonates; an intraoral examination was performed by 2 standardized examiners. The prevalence of bisphosphonate-related necrosis in 75 patients was 2.6%; the most common malignancy was breast cancer (84.0%), followed by prostate cancer (16.0%). Exostosis was present in 9.3% of patients and the mean Decayed, Missing, Filled Teeth index was 4.64; 44.0% of the study group had a Community Periodontal Index value between 2 and 2.9 (mean, 0.60). A detailed intraoral assessment must be performed before initiating treatment with bisphosphonates to identify risk factors for osteonecrosis.</abstract><cop>Korea (South)</cop><pub>The Korean Association of Oral and Maxillofacial Surgeons</pub><pmid>28053907</pmid><doi>10.5125/jkaoms.2016.42.6.365</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-3112-4893</orcidid><orcidid>https://orcid.org/0000-0002-1250-2564</orcidid><orcidid>https://orcid.org/0000-0002-5147-9133</orcidid><orcidid>https://orcid.org/0000-0002-6981-8025</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-7550
ispartof 대한구강악안면외과학회지, 2016, 42(6), , pp.365-369
issn 2234-7550
2234-5930
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_1293027
source PubMed Central
subjects Original
치의학
title Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A49%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20osteonecrosis%20of%20the%20jaw%20and%20oral%20characteristics%20of%20oncologic%20patients%20treated%20with%20bisphosphonates%20at%20the%20General%20Hospital%20of%20Mexico&rft.jtitle=Journal%20of%20the%20Korean%20Association%20of%20Oral%20and%20Maxillofacial%20Surgeons&rft.au=Cuevas-Gonz%C3%A1lez,%20Mar%C3%ADa%20Ver%C3%B3nica&rft.date=2016-12-01&rft.volume=42&rft.issue=6&rft.spage=365&rft.epage=369&rft.pages=365-369&rft.issn=2234-7550&rft.eissn=2234-5930&rft_id=info:doi/10.5125/jkaoms.2016.42.6.365&rft_dat=%3Cproquest_nrf_k%3E1855790122%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-9d1660b5a74ceaf07f5777da7d81f7651620a25c99b7fd65dadc60b605db232a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1855790122&rft_id=info:pmid/28053907&rfr_iscdi=true